Cyclin-dependent kinase 1 as a potential target for lycorine against hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2021 at "Biochemical pharmacology"
DOI: 10.1016/j.bcp.2021.114806
Abstract: The pathological changes and possible underlying molecular mechanisms of hepatocellular carcinoma (HCC) are currently unclear. Effective treatment of this pathological state remains a challenge. The purpose of this study is to obtain some key genes… read more here.
Keywords: hepatocellular carcinoma; cdk1; target lycorine; cyclin dependent ... See more keywords